 NEW YORK, Jan. 19, 2021 PRNewswire -- Scopus BioPharma Inc. Nasdaq: SCPS today announced the completion of clinical lot manufacturing fulfilling the requirements for the planned Phase 1 clinical trial for non-Hodgkins lymphoma. This is a key milestone to enable finalization of the... 